Near-infrared Image Guided Surgery in Pancreatic Adenocarcinoma

NCT02743975 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Insufficient tumor-to-background ratios in the first three dose groups

Conditions

Pancreatic Cancer
Pancreatic Adenocarcinoma

Interventions

DRUG: Bevacizumab-800CW

Sponsor

University Medical Center Groningen

Collaborators

[object Object]